CAVA director granted 1,881 RSUs in equity award

Amouyal Philippe reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Amouyal Philippe reported acquisition or exercise transactions in this Form 4 filing.

CAVA GROUP, INC. director Philippe Amouyal received a grant of 1,881 restricted stock units (RSUs) of common stock as equity compensation. These RSUs vest in full on the earlier of June 22, 2027 or the business day before CAVA’s next annual stockholder meeting, assuming continued service. Following this grant, Amouyal holds 19,955 shares and RSUs in total, including unvested RSUs.

Insider Trade Summary

Grant/Award: 1,881 shares

Grant/Award 1 txn

Insider Amouyal Philippe

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,881	$0.00	$0.00

Holdings After Transaction: Common Stock — 19,955 shares (Direct)

Footnotes (2)

1. F1. Reflects a grant of restricted stock units ("RSUs"), which vest in full on the earlier of (i) June 22, 2027 and (ii) the business day before the date of the next annual meeting of the stockholders of CAVA Group Inc. (the "Issuer"), subject to the reporting person's continued service through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.0001 per share upon settlement.
2. F2. Includes unvested RSUs.

Key Figures

RSU grant size: 1,881 RSUs Grant price per share: $0.0000 per share Total holdings after grant: 19,955 shares/RSUs +1 more

4 metrics

RSU grant size 1,881 RSUs Grant of restricted stock units to director on June 22, 2026

Grant price per share $0.0000 per share Reported transaction price for RSU acquisition

Total holdings after grant 19,955 shares/RSUs Includes unvested RSUs following this award

RSU vesting date June 22, 2027 Vests earlier of this date or day before next annual meeting

Key Terms

restricted stock units ("RSUs"), vest in full, annual meeting of the stockholders, contingent right, +1 more

5 terms

restricted stock units ("RSUs") financial

"Reflects a grant of restricted stock units ("RSUs"), which vest in full on the earlier of (i) June 22, 2027..."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vest in full financial

"RSUs, which vest in full on the earlier of (i) June 22, 2027 and (ii) the business day before the date..."

annual meeting of the stockholders regulatory

"the business day before the date of the next annual meeting of the stockholders of CAVA Group Inc."

contingent right financial

"Each RSU represents a contingent right to receive one share of the Issuer's common stock..."

unvested RSUs financial

"Includes unvested RSUs."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CAVA (CAVA) director Philippe Amouyal report in this Form 4?

Philippe Amouyal reported receiving 1,881 restricted stock units (RSUs) of CAVA common stock as an equity grant. This is a non-cash, compensation-related award and not an open-market stock purchase or sale.

How many CAVA (CAVA) shares and RSUs does Philippe Amouyal hold after this grant?

After the grant, Philippe Amouyal holds a total of 19,955 CAVA common shares and RSUs. This total explicitly includes unvested RSUs as disclosed in the filing’s footnotes.

When do Philippe Amouyal’s new CAVA RSUs vest?

The 1,881 CAVA RSUs vest in full on the earlier of June 22, 2027 or the business day before CAVA’s next annual stockholder meeting. Vesting is conditioned on Amouyal’s continued service through the applicable vesting date.

Are the CAVA (CAVA) RSUs a cash transaction for Philippe Amouyal?

No, the RSU grant is not a cash transaction. Each restricted stock unit represents a contingent right to receive one share of CAVA common stock upon settlement, at no stated purchase price per share in this filing.

Does this CAVA Form 4 show any stock sales by Philippe Amouyal?

This Form 4 does not show any open-market stock sales by Philippe Amouyal. It only reports an acquisition of 1,881 RSUs as a grant, with no sell transactions listed in the transaction summary.

What conditions apply to Philippe Amouyal’s CAVA RSU grant?

Vesting of the 1,881 CAVA RSUs requires Amouyal’s continued service through the earlier of June 22, 2027 or the business day before the next annual stockholder meeting. Unvested RSUs are included in his reported total holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/24/2026 - 04:01 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Amouyal Philippe

(Last) (First) (Middle)

C/O CAVA GROUP, INC.

14 RIDGE SQUARE NW, SUITE 500

(Street)

WASHINGTON DISTRICT OF COLUMBIA 20016

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAVA GROUP, INC. [ CAVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/22/2026		A(1)		1,881	A	$0	19,955(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects a grant of restricted stock units ("RSUs"), which vest in full on the earlier of (i) June 22, 2027 and (ii) the business day before the date of the next annual meeting of the stockholders of CAVA Group Inc. (the "Issuer"), subject to the reporting person's continued service through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.0001 per share upon settlement.

2. Includes unvested RSUs.

Remarks:

	/s/ Amit Patel, as Attorney-in-Fact	06/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)